Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JH013 in Primary Sjögren's Syndrome
NCT07818694Phase 1Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Dec 2027
01
Overview
Phase 1, open-label trial of JH013 in primary Sjögren's syndrome (9 arms). Primary endpoint: Number of participants with adverse events. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
JH013
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT07818694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07818694.